Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1994 2
1995 3
1996 2
1998 1
1999 4
2001 1
2002 1
2005 2
2010 1
2011 1
2014 1
2018 1
2019 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Development of the ovarian follicular epithelium.
Rodgers RJ, Lavranos TC, van Wezel IL, Irving-Rodgers HF. Rodgers RJ, et al. Among authors: lavranos tc. Mol Cell Endocrinol. 1999 May 25;151(1-2):171-9. doi: 10.1016/s0303-7207(99)00087-8. Mol Cell Endocrinol. 1999. PMID: 10411332 Review.
Roles of extracellular matrix in follicular development.
Rodgers RJ, van Wezel IL, Irving-Rodgers HF, Lavranos TC, Irvine CM, Krupa M. Rodgers RJ, et al. Among authors: lavranos tc. J Reprod Fertil Suppl. 1999;54:343-52. J Reprod Fertil Suppl. 1999. PMID: 10692866 Review.
Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103).
Lindemann K, Beale PJ, Rossi E, Goh JC, Vaughan MM, Tenney ME, Martyn JK, Sommeijer D, Iglesias JL, Kremmidiotis G, Simpson J, Doolin E, Lavranos TC, Leske A, Veillard AS, Espinoza D, Stockler MR, Rischin D; For ANZGOG and HCRN Collaborative Groups. Lindemann K, et al. Among authors: lavranos tc. Cancer Chemother Pharmacol. 2019 Jan;83(1):97-105. doi: 10.1007/s00280-018-3706-5. Epub 2018 Oct 27. Cancer Chemother Pharmacol. 2019. PMID: 30368585 Clinical Trial.
Discovery of 7-hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.
Flynn BL, Gill GS, Grobelny DW, Chaplin JH, Paul D, Leske AF, Lavranos TC, Chalmers DK, Charman SA, Kostewicz E, Shackleford DM, Morizzi J, Hamel E, Jung MK, Kremmidiotis G. Flynn BL, et al. Among authors: lavranos tc. J Med Chem. 2011 Sep 8;54(17):6014-27. doi: 10.1021/jm200454y. Epub 2011 Aug 5. J Med Chem. 2011. PMID: 21774499 Free PMC article.
22 results